Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03144245
Title Study of AMV564 in Patients With AML
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Amphivena Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California, San Francisco San Francisco California 94143 United States Details
Northwestern Chicago Illinois 60611 United States Details
Johns Hopkins University Baltimore Maryland 21287 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
New York Medical College Hawthorne New York 10532 United States Details
Weill Cornell Medical College, The New York Presbyterian Hospital New York New York 10021 United States Details
The Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
MD Anderson Cancer Center, The University of Texas Houston Texas 70030-4009 United States Details
Fred Hutchinson Cancer Research Seattle Washington 98109-1024 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field